Back
Xerox Holdings Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
45
XRX
Xerox Holdings
Last Price:
10.19
Seasonality Move:
4.03%
Sell
30
ASND
Ascendis Pharma AS
Last Price:
131.97
Seasonality Move:
11.38%
Sell
45
Xerox Holdings (XRX)
is a Sell
Is Xerox Holdings a Buy, Sell or Hold?
- The current Xerox Holdings [XRX] share price is $10.38. The Score for XRX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- XRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $139.14. The Score for ASND is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XRX Stock Price Chart
What is Xerox Holdings's stock price today?
-
The Xerox Holdings share price today is $10.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XRX is experiencing selling pressure, which indicates risk of future bearish movement.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $139.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
XRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 48.94 | Sell |
| Chaikin Money Flow: | -550272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.12 - 10.62) | Buy |
| Bollinger Bands (100): | (10.08 - 13.12) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.85 | Buy |
| Relative Strength Index (14 RSI): | 49.18 | Sell |
| Chaikin Money Flow: | -202245 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (122.38 - 149.98) | Buy |
| Bollinger Bands (100): | (125.51 - 142.39) | Buy |
XRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.38 | Sell |
| 20-day SMA: | 10.34 | Buy |
| 50-day SMA: | 10.4 | Sell |
| 200-day SMA: | 14.27 | Sell |
| 8-day EMA: | 10.37 | Buy |
| 20-day EMA: | 10.39 | Sell |
| 50-day EMA: | 10.71 | Sell |
| 200-day EMA: | 13.02 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.63 | Sell |
| 20-day SMA: | 139.77 | Sell |
| 50-day SMA: | 135.45 | Buy |
| 200-day SMA: | 137.57 | Buy |
| 8-day EMA: | 143.16 | Sell |
| 20-day EMA: | 141.12 | Sell |
| 50-day EMA: | 137.51 | Buy |
| 200-day EMA: | 131.46 | Buy |
Xerox Holdings Earnings Growth & XRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and an increase next year of $0.09 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.61 per share, and an increase next year of $4.34 per share.
Xerox Holdings Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||